Plasma thyroxine, 3,3',5-triiodothyronine and 3,3',5'-triiodothyronine during beta-adrenergic blockade in hyperthyroidism

The Journal of Clinical Endocrinology and Metabolism
R P VerhoevenM A Schalekamp

Abstract

Plasma thyroxine (T4), 3,3',5-triiodothyronine (T3) and 3,3',5'-triiodothyronine (rT3) were measured in 16 patients with Graves' disease. Patients were studied under the following conditions: first without any treatment, then, during beta-adrenergic blockade with propranolol, and finally after euthyroidism had been attained by carbimazole. During propranolol T3/T4 ratio decreased, whereas T4 remained unchanged. After carbimazole T3/T4 ratio returned to its pretreatment value. rT3/T4 ratio showed opposite changes. These results suggest that peripheral conversion of T4 into T3 and rT3 in hyperthyroidism is, at least partly, dependent on the functional status of the beta-adrenergic system. Suppressed peripheral conversion of T4 into T3 during beta-adrenergic blocking agents may contribute to the beneficial effects of these drugs in thyrotoxicosis.

Citations

Jan 1, 1982·European Journal of Clinical Pharmacology·A AroH Sundquist
Oct 1, 1980·European Journal of Clinical Pharmacology·O R NilssonL Tegler
Jul 27, 2010·Rheumatology International·Kundan KumarAlakendu Ghosh
Dec 1, 1982·The American Journal of Medicine·D S CooperE C Ridgway
Jan 1, 1982·Pharmacology & Therapeutics·N J RothwellD Stribling
Jan 1, 1991·Thyroid : Official Journal of the American Thyroid Association·W M Wiersinga
Jul 1, 1978·Clinical Endocrinology·J SaundersP H Sönksen
May 1, 1979·Clinical Endocrinology·J FeelyJ Crooks
Mar 1, 1990·Clinical Endocrinology·O EberP Költringer
Oct 22, 1977·British Medical Journal
Nov 1, 1982·Postgraduate Medical Journal·N S JaggaraoD A Chamberlain
Jan 1, 1979·Pharmacology & Therapeutics. Part B: General & Systematic Pharmacology·H Winterhoff, H Sourgens
Mar 1, 1978·Clinics in Endocrinology and Metabolism·L E Braverman
Sep 1, 1980·Clinical Endocrinology·J HowP D Bewsher
Dec 1, 1981·Clinical Endocrinology·S KaurI Ramsay
Jul 1, 1992·The American Journal of Medicine·D L Geffner, J M Hershman
Dec 1, 1979·British Journal of Clinical Pharmacology·L E MurchisonP D Bewsher
Dec 1, 1981·British Journal of Clinical Pharmacology·G R JonesD Wynford-Thomas
Jan 1, 1979·Acta Medica Scandinavica. Supplementum·I B LumholtzK Siersbaek-Nielsen
Jun 1, 1982·British Journal of Clinical Pharmacology·N R PedenJ Crooks
Dec 1, 1983·Journal of Endocrinological Investigation·R Rajatanavin, L E Braverman
Sep 1, 1983·Scandinavian Journal of Clinical and Laboratory Investigation·G LindstedtA Svanborg
Feb 1, 1981·Drug Intelligence & Clinical Pharmacy·T J Nester
Jan 1, 1983·Acta Medica Scandinavica. Supplementum·O R Nilsson, B E Karlberg

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.